Keyphrases
Docetaxel
100%
Taxanes
100%
Cancer Gene Therapy
100%
Transgene Expression
100%
Hormone-sensitive Prostate Cancer
100%
Paclitaxel
80%
Gene Therapy
60%
Adenovirus
60%
Chemotherapy
60%
β-Galactosidase (β-Gal)
40%
Cytomegalovirus Promoter
40%
Primary Therapy
20%
High Dose
20%
Complementary DNA (cDNA)
20%
Specific Genes
20%
Recombinant Adenovirus
20%
Metastatic Cancer
20%
New Therapeutics
20%
Therapeutic Regimen
20%
Western Blot Analysis
20%
P53 Protein
20%
P21Cip1
20%
Virus-infected Cell
20%
Growth Inhibitor
20%
Promoter Activity
20%
Prostate Cancer Cell Lines
20%
PC-3
20%
Growth Assay
20%
DU145
20%
In Vitro Growth
20%
Non-target Organisms
20%
Virus Uptake
20%
Future Therapies
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Docetaxel
100%
Androgen
100%
Taxane
100%
Paclitaxel
80%
Adenoviridae
80%
Chemotherapy
60%
Cytomegalovirus
40%
Antiinfective Agent
40%
Galactosidase
40%
Western Blot
20%
Protein P53
20%
Growth Inhibitor
20%
Complementary DNA
20%